Astec LifeSciences Ltd — Quarterly Results & Earnings

₹540.60

-7.01%

Profit Growth YoY36.64%Latest quarter

Sales Growth YoY-25.20%Latest quarter

Sales CAGR 5Y-6.11%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+36.64%

🔥 Exceptional growth

YoY Sales Growth-25.20%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

10.02%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

-1.47

ROE

-45.29%

ROCE

-12.86%

💡

Growth Analysis

Astec LifeSciences Ltd reported YoY profit growth of 36.64% and revenue growth of -25.20% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at -6.11% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Astec LifeSciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pesticides & Agrochemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.